In secondary MR, given the lesser benefit of surgery, TEER is indicated even for patients whose surgical risk is not prohibitive if they have NYHA class II or IV symptoms refractory to medical therapy, ejection fraction 20 to 50%, LV end-systolic diameter ≤ 70 mm, pulmonary artery systolic pressure ≤ 70 mm Hg, and an anatomically suitable valve.